Chief Executive Officer
Dr Murray brings more than 20 years’ of drug discovery and early development experience across a range of therapeutic areas, including inflammation, gastrointestinal, neurodegeneration, psychiatry and dermatology. He has held leadership roles at Shire, AstraZeneca, Merck , Calcico Therapeutics, Chronos Therapeutics & Polleo Pharma.
Prior to co-founding Polleo Pharma and raising investment to fund the portfolio, Dr Murray was Senior Director and Head of Discovery Biology for Shire Speciality Pharmaceuticals, focused on CNS and GI disorders.
Dr Murray holds a PhD from The School of Pharmacy UCL, a BSc from the University of Strathclyde and an MBA from Alliance Manchester Business School
Chief Scientific Officer
Dr Quibell is a Medicinal Chemist with 20 years experience. He began his drug discovery career with Peptide Therapeutics before taking up the position of Chief Scientific Officer at Amura Therapeutics. In 2010, Martin joined Shire Pharmaceuticals as Senior Director of Exploratory Projects where he established an internal Medicinal Chemistry Team to provide creative and patentable new product ideas for Shire Speciality Pharma.
Dr Quibell graduated from the University of Birmingham and completed his postdoctoral research at the Medical Research Council in Cambridge.
Chief Operating Officer
Dr Schulz-Utermoehl has over 17 years’ experience in the pharmaceutical industry, spanning early and late-stage discovery research and preclinical development. He has held senior roles at Shire, AstraZeneca and Merck and was one of the founders of Polleo Pharma.
Prior to co-founding Polleo Pharma, Dr Schulz-Utermoehl was a Director within the Exploratory Projects Department for Shire Speciality Pharmaceuticals in the UK. Dr Schulz-Utermoehl carried out post-doctoral research at Novo Nordisk.
Dr Schulz-Utermoehl holds a PhD in Biochemistry from Imperial College London, an MSc in Toxicology from the Royal Postgraduate Medical School, London and a BSc in Pharmacology/Physiology from the University of Leeds.
BioHub, Alderley Park, UK
Incorporated in England and Wales with registered number 11249269